Renal dysfunction in heart failure patients: what is the evidence?

被引:27
作者
Saltzman, Heath E. [1 ]
Sharma, Kumar [1 ]
Mather, Paul J. [1 ]
Rubin, Sharon [1 ]
Adams, Suzanne [1 ]
Whellan, David Joshua [1 ]
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Jefferson Heart Inst,Dept Med, Ctr Novel Therapies Kidney Dis, Philadelphia, PA 19107 USA
关键词
heart failure; renal dysfunction; worsened outcomes;
D O I
10.1007/s10741-007-9006-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Congestive heart failure (CHF) is an increasingly common medical condition and the fastest growing cardiovascular diagnosis in North America. Over one-third of patients with heart failure also have renal insufficiency. It has been shown that renal insufficiency confers worsened outcomes to patients with heart failure. However, a majority of the larger and therapy-defining heart failure medication and device trials exclude patients with advanced renal dysfunction. These studies also infrequently perform subgroup analyses based on the degree of renal dysfunction. The lack of information on heart failure patients who have renal insufficiency likely contributes to their being prescribed mortality and morbidity reducing medications and receiving diagnostic and therapeutic procedures at lower rates than heart failure patients with normal renal function. Inclusion of patients with renal insufficiency in heart failure studies and published guidelines for medication, device, and interventional therapies would likely improve patient outcomes.
引用
收藏
页码:37 / 47
页数:11
相关论文
共 93 条
[1]  
AHMED A, 2000, ARCH INTERN MED, V160, P685
[2]   Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction [J].
Al-Ahmad, A ;
Rand, WM ;
Manjunath, G ;
Konstam, MA ;
Salem, DN ;
Levey, AS ;
Sarnak, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (04) :955-962
[3]  
Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
[4]  
[Anonymous], KIDN DIS OUTC QUAL I
[5]  
Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002
[6]   Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].
Bardy, GH ;
Lee, KL ;
Mark, DB ;
Poole, JE ;
Packer, DL ;
Boineau, R ;
Domanski, M ;
Troutman, C ;
Anderson, J ;
Johnson, G ;
McNulty, SE ;
Clapp-Channing, N ;
Davidson-Ray, LD ;
Fraulo, ES ;
Fishbein, DP ;
Luceri, RM ;
Ip, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237
[7]   Ultrafiltration versus usual care for hospitalized patients with heart failure - The relief for acutely fluid-overloaded patients with decompensated congestive heart failure (RAPID-CHF) trial [J].
Bart, BA ;
Boyle, A ;
Bank, AJ ;
Anand, I ;
Olivari, MT ;
Kraemer, M ;
Mackedanz, S ;
Sobotka, PA ;
Schollmeyer, M ;
Goldsmith, SR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (11) :2043-2046
[8]   Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction [J].
Beattie, JN ;
Soman, SS ;
Sandberg, KR ;
Yee, J ;
Borzak, S ;
Garg, M ;
McCullough, PA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (06) :1191-1200
[9]  
*BED LAB, 2005, MILR LACT PACK INS
[10]   Renal insufficiency as an independent predictor of mortality among women with heart failure [J].
Bibbins-Domingo, K ;
Lin, F ;
Vittinghof, E ;
Barrett-Connor, E ;
Grady, D ;
Shlipak, MG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (08) :1593-1600